Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study

BACKGROUND: Helicobacter pylori (H. pylori) is important cause of peptic ulcer and gastric cancer. Moxifloxacin is effective antibiotic for treatment for H. pylori. However, there were limited studies as first line therapy. Probiotics had been shown to decrease therapy-related side-effect and increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chotivitayatarakorn, Peranart, Mahachai, Varocha, Vilaichone, Ratha-Korn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747412/
https://www.ncbi.nlm.nih.gov/pubmed/29072432
http://dx.doi.org/10.22034/APJCP.2017.18.10.2839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747412/
https://www.ncbi.nlm.nih.gov/pubmed/29072432
http://dx.doi.org/10.22034/APJCP.2017.18.10.2839

Ejemplares similares